Cargando…
Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional study
AIMS: The aim of this study was to investigate a real-world heart failure (HF) cohort regarding (1) prevalence of known diabetes mellitus (DM), undiagnosed DM and pre-diabetes, (2) if hf treatment differs depending on glycaemic status and (3) if treatment of DM differs depending on HF phenotype. MET...
Autores principales: | Håkansson, Erik, Brunström, Mattias, Norberg, Helena, Själander, Sara, Lindmark, Krister |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748948/ https://www.ncbi.nlm.nih.gov/pubmed/36600650 http://dx.doi.org/10.1136/openhrt-2022-002133 |
Ejemplares similares
-
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
por: Håkansson, Erik, et al.
Publicado: (2021) -
β-Blockers in hypertension, diabetes, heart failure and acute
myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015) -
Risk factors of diabetic cardiac autonomic neuropathy in patients with type 1 diabetes mellitus: a meta-analysis
por: Dafaalla, Mohamed D, et al.
Publicado: (2016) -
Effectiveness of an impedance cardiography guided treatment strategy to improve blood pressure control in a real-world setting: results from a pragmatic clinical trial
por: Wang, Luyan, et al.
Publicado: (2021) -
Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data
por: Kohsaka, Shun, et al.
Publicado: (2020)